Viewing Study NCT04838704


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-01-05 @ 10:36 PM
Study NCT ID: NCT04838704
Status: COMPLETED
Last Update Posted: 2025-06-04
First Post: 2021-04-05
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Ruxolitinib With Calcineurin Inhibitor and Methotrexate vs. Calcineurin Inhibitor Plus Methotrexate and Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis for HLA-haploidentical Hematopoietic Stem Cell Transplantation
Sponsor: Zhejiang University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graft Versus Host Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Graft Versus Host Disease View
None ruxolitinib View
None HLA-haploidentical hematopoietic stem cell transplantation View